Ferlitsch Monika, Heinze Georg, Salzl Petra, Britto-Arias Martha, Waldmann Elisabeth, Reinhart Karoline, Bannert Christina, Fasching Elisabeth, Knoflach Peter, Weiss Werner, Trauner Michael, Ferlitsch Arnulf
Quality Assurance Working Group, Austrian Society of Gastroenterology and Hepatology, Freyung 6, 1010, Vienna, Austria,
Med Oncol. 2014 Sep;31(9):151. doi: 10.1007/s12032-014-0151-0. Epub 2014 Aug 14.
Due to high costs and limited availability of screening colonoscopy, some screening programs require a positive fecal occult blood test (FOBT) before screening colonoscopy is remunerated. As male sex is a strong predictor of adenoma and advanced adenoma, we evaluated whether a positive FOBT or male sex is a stronger risk factor for adenoma and advanced adenoma. FOBT and screening colonoscopy results from 18.665 consecutive patients participating in a "national health check program" between 2009 and 2011 were included in this cohort study. Age-corrected adenoma detection rates (ADR), advanced adenoma detection rates (AADR) and carcinoma detection rates were calculated for men and women according to FOBT result separately. ADR and AADR in FOBT-positive men (34.6 and 11.8 %) and FOBT-negative men (29.1 and 7.6 %) were higher than ADR and AADR in FOBT-positive women (20 and 6.9 %) and in FOBT-negative women (17.6 and 4.4 %), (p = 0.0003). Men with negative FOBT were at higher risk of having an adenoma and advanced adenoma than women with positive FOBT (p < 0.0001). Odds ratios of a positive FOBT for ADR and AADR were 1.3 (1.1-1.5) (p = 0.0047) and 1.6 (1.2-2.1) (p < 0.0001), respectively. Odds ratios of male sex to predict ADR and AADR were significantly higher with 1.9 (1.8-2.1) and 1.8 (1.6-2), respectively (p < 0.001). Male sex is a stronger predictor for colorectal adenoma and advanced adenoma than positive FOBT. These results should be taken into account analyzing FOBT-based screening programs.
由于筛查结肠镜检查成本高昂且可及性有限,一些筛查项目要求在筛查结肠镜检查获得报销之前粪便潜血试验(FOBT)呈阳性。由于男性是腺瘤和进展性腺瘤的有力预测指标,我们评估了FOBT阳性或男性性别是否是腺瘤和进展性腺瘤更强的危险因素。本队列研究纳入了2009年至2011年期间参加“国民健康检查项目”的18665例连续患者的FOBT和筛查结肠镜检查结果。根据FOBT结果分别计算男性和女性的年龄校正腺瘤检出率(ADR)、进展性腺瘤检出率(AADR)和癌检出率。FOBT阳性男性的ADR和AADR(分别为34.6%和11.8%)以及FOBT阴性男性的ADR和AADR(分别为29.1%和7.6%)高于FOBT阳性女性(分别为20%和6.9%)和FOBT阴性女性(分别为17.6%和4.4%)(p = 0.0003)。FOBT阴性的男性患腺瘤和进展性腺瘤的风险高于FOBT阳性的女性(p < 0.0001)。FOBT阳性对于ADR和AADR的比值比分别为1.3(1.1 - 1.5)(p = 0.0047)和1.6(1.2 - 2.1)(p < 0.0001)。男性性别预测ADR和AADR的比值比显著更高,分别为1.9(1.8 - 2.1)和1.8(1.6 - 2)(p < 0.001)。男性性别比FOBT阳性是结直肠腺瘤和进展性腺瘤更强的预测指标。在分析基于FOBT的筛查项目时应考虑这些结果。